Taipei Exchange - Delayed Quote TWD

Genovate Biotechnology Co., Ltd. (4130.TWO)

Compare
25.30
+0.45
+(1.81%)
At close: 1:30:35 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
512,082.00
528,512.00
438,759.00
434,254.00
472,723.00
Cost of Revenue
315,209.00
317,596.00
283,889.00
284,500.00
279,617.00
Gross Profit
196,873.00
210,916.00
154,870.00
149,754.00
193,106.00
Operating Expense
181,645.00
183,923.00
168,763.00
150,917.00
153,639.00
Operating Income
15,228.00
26,993.00
-13,893.00
-1,163.00
39,467.00
Net Non Operating Interest Income Expense
5,945.00
4,751.00
2,392.00
1,353.00
1,913.00
Pretax Income
20,987.00
30,825.00
-9,001.00
3,568.00
40,756.00
Tax Provision
5,121.00
1,491.00
3,322.00
3,196.00
2,025.00
Net Income Common Stockholders
15,866.00
29,334.00
-12,323.00
372.00
38,731.00
Diluted NI Available to Com Stockholders
15,866.00
29,334.00
-12,323.00
372.00
38,731.00
Basic EPS
0.14
0.26
-0.11
0.00
0.35
Diluted EPS
0.14
0.26
-0.11
0.00
0.35
Basic Average Shares
112,557.28
112,657.28
111,128.76
111,112.28
111,112.28
Diluted Average Shares
112,693.24
112,793.24
111,128.76
111,163.78
111,314.16
Total Expenses
496,854.00
501,519.00
452,652.00
435,417.00
433,256.00
Net Income from Continuing & Discontinued Operation
15,866.00
29,334.00
-12,323.00
372.00
38,731.00
Normalized Income
15,866.00
29,320.68
-12,325.40
374.40
38,702.49
Interest Income
6,303.00
5,018.00
2,673.00
1,605.00
2,166.00
Interest Expense
358.00
267.00
281.00
252.00
253.00
Net Interest Income
5,945.00
4,751.00
2,392.00
1,353.00
1,913.00
EBIT
21,345.00
31,092.00
-8,720.00
3,820.00
41,009.00
EBITDA
58,780.00
67,640.00
27,368.00
39,636.00
76,218.00
Reconciled Cost of Revenue
315,209.00
317,596.00
283,889.00
284,500.00
279,617.00
Reconciled Depreciation
37,435.00
36,548.00
36,088.00
35,816.00
35,209.00
Net Income from Continuing Operation Net Minority Interest
15,866.00
29,334.00
-12,323.00
372.00
38,731.00
Total Unusual Items Excluding Goodwill
--
14.00
3.00
-3.00
30.00
Total Unusual Items
--
14.00
3.00
-3.00
30.00
Normalized EBITDA
58,780.00
67,626.00
27,365.00
39,639.00
76,188.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
0.68
0.60
-0.60
1.49
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
 
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
 
4167.TWO Savior Lifetec Corporation
19.75
-0.25%
 
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%
 
6535.TWO Lumosa Therapeutics Co., Ltd.
263.50
-0.57%
 
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
 
4142.TW Adimmune Corporation
22.60
-1.74%
 
4162.TWO PharmaEngine, Inc.
95.10
+2.15%
 
6547.TWO Medigen Vaccine Biologics Corporation
47.60
-3.94%
 
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%